These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3866270)

  • 21. Enoxacin: a potent inducer of filamentous Escherichia coli cells (a note).
    Uri JV; Actor P
    Acta Microbiol Hung; 1985; 32(2):197-200. PubMed ID: 3933273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bactericidal activity of ofloxacin against staphylococci.
    Lewin CS; Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):151-3. PubMed ID: 16312348
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteria.
    Rudrik JT; Cavalieri SJ; Britt EM
    Antimicrob Agents Chemother; 1984 Jul; 26(1):97-100. PubMed ID: 6591853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antibacterial activity of enoxacin (CI-919).
    Fernandes CJ; Munro R; Toohey M; Shanker S; Mallon R; Daley D; Harland GS; Stevens DA; Wilson RD; Ackerman VP
    Pathology; 1986 Apr; 18(2):240-2. PubMed ID: 3093961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Resistance of gram-negative bacilli to 6 aminoglycosides].
    Broussain MT; Pinto ME; Cona E
    Rev Med Chil; 1985 Dec; 113(12):1210-6. PubMed ID: 3016857
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility pattern of bacterial isolates from post-operative wound infections.
    Arya M; Arya PK; Biswas D; Prasad R
    Indian J Pathol Microbiol; 2005 Apr; 48(2):266-9. PubMed ID: 16758692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Enzymatic mechanisms of resistance to aminoglycoside antibiotics in gram negative bacilli from Chilean hospitals].
    Del Solar E; García A; Bello H; Domínguez M; González G; Zemelman R
    Rev Med Chil; 1995 Mar; 123(3):293-7. PubMed ID: 8525167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
    Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
    Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
    Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH; Lu CD
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro sensitivity of legionellas, meningococci and mycoplasmas to ciprofloxacin and enoxacin.
    Fallon RJ; Brown WM
    J Antimicrob Chemother; 1985 Jun; 15(6):787-9. PubMed ID: 3161857
    [No Abstract]   [Full Text] [Related]  

  • 34. Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
    Zimmermann L; Bussière A; Ouberai M; Baussanne I; Jolivalt C; Mingeot-Leclercq MP; Décout JL
    J Med Chem; 2013 Oct; 56(19):7691-705. PubMed ID: 24083676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ethylenediaminetetraacetic acid and gentamicin on the antibacterial activity of pyridone carboxylic acid derivatives against gram-negative bacilli.
    Miyake Y; Mitsui K; Suginaka H
    J Antimicrob Chemother; 1986 Mar; 17(3):327-32. PubMed ID: 3084441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antibacterial activity of aztreonam against gram-negative bacilli isolated in 1985.
    Miyake Y; Yokoyama T; Nakano H; Kuwabara M; Yamakido M; Suginaka H
    Hiroshima J Med Sci; 1988 Sep; 37(3):115-7. PubMed ID: 3248945
    [No Abstract]   [Full Text] [Related]  

  • 37. Correlation between antibiotic sensitivity testing by conventional and conductivity measurements.
    Hogg GM; Patterson MF; Barr JG
    J Appl Bacteriol; 1987 Mar; 62(3):189-95. PubMed ID: 3597200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro activity of aztreonam in combination with four other antibiotics against gram-negative bacilli and Staphylococcus aureus.
    Ampel NM; Moon-McDermott L; Keating M; Zinner SH
    J Antimicrob Chemother; 1984 Apr; 13(4):398-9. PubMed ID: 6539326
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro synergistic activity of colistin with aminoglycosides, beta-lactams and rifampin against multidrug-resistant gram-negative bacteria.
    Chitnis S; Chitnis V; Chitnis DS
    J Chemother; 2007 Apr; 19(2):226-9. PubMed ID: 17434834
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rifampicin: laboratory study on Gram negative bacteria and Staphylococcus aureus].
    Silva J; Zemelman R; Angélica Mondaca M
    Rev Latinoam Microbiol; 1978; 20(2):69-73. PubMed ID: 288114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.